Right. So SWOG 0532 is more a reflection or continuation of SWOG 0342 rather than someone being impressed with the FLEX data.
I'm just stewing in my own juices about the rumor mill a-churnin and we hear squat. And we have to wait another 7.5 months before ASCO. Seems like a fair disclosure violation to me.
Saltz was running the 1st line trial of Folfiri+/-erb vs Folfox+/-erb and that was the trial that was closed due to lack of enrollment. Because Avastin had become available.